tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Capricor sinks after STAT report of cancelled FDA panel review

The shares are down 33%, or $3.93, to $8.01 in afternoon trading.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1